首页>
外国专利>
Treatment of heart failure in non-human animal mammals by an aldosterone antagonist
Treatment of heart failure in non-human animal mammals by an aldosterone antagonist
展开▼
机译:醛固酮拮抗剂治疗非人类哺乳动物的心力衰竭
展开▼
页面导航
摘要
著录项
相似文献
摘要
Veterinary composition for the treatment of heart deficiency in non-human mammalian subjects, comprises aldosterone antagonist, and vehicles, where the aldosterone antagonist is present in an effective therapeutic dose of greater than 1 mg/kg/day to less than 5 mg/kg/day, preferably 4 mg/kg/day, as a single dose. An independent claim is included for a veterinary kit for the treatment of heart failure in non-human subjects, comprising at least a compartment comprising a daily dose of the aldosterone antagonist of greater than 1 mg/kg/day to less than 5 mg/kg/day, preferably 4 mg/kg/day. ACTIVITY : Cardiant. MECHANISM OF ACTION : Aldosterone antagonist; Angiotensin converting enzyme inhibitors; Angiotensin II receptor AT-1 antagonists; Beta blocker; Calcium antagonists.
展开▼
机译:用于治疗非人类哺乳动物受试者的心脏缺乏症的兽医用组合物,包括醛固酮拮抗剂和媒介物,其中醛固酮拮抗剂以大于1 mg / kg /天至小于5 mg / kg /天的有效治疗剂量存在单剂量,优选每天4mg / kg /天。包括用于治疗非人类受试者心力衰竭的兽医试剂盒的独立权利要求,其包括至少一个隔室,该隔室包含每日剂量大于1 mg / kg /天至小于5 mg / kg的醛固酮拮抗剂。 /天,优选4mg / kg /天。活动:Cardiant。作用机理:醛固酮拮抗剂;血管紧张素转换酶抑制剂;血管紧张素II受体AT-1拮抗剂; Β受体阻断药;钙拮抗剂。
展开▼